Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Initial Chemotherapy for Locally Advanced and Metastatic NUT CarcinomaJia Luo, Michelle Sanchez, Elinton Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
NPJ Precision Oncology|July 9, 2025
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancerKarl Semaan, Rashad Nawfal, John Canniff, et al.
Nature|September 28, 2010
Selective inhibition of BET bromodomainsPanagis Filippakopoulos, Jun Qi, Sarah Picaud, et al.
Histopathology|March 24, 2025
Primary cutaneous NUT adnexal carcinoma: morphologic, genetic and methylation analysis of seven new cases with comparison to extracutaneous NUT carcinoma and NUTM1-rearranged porocarcinomaMélanie Legrand, Baptiste Louveau, Amélie Osio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 25, 2021
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?Alexander Marx, John K C Chan, Lara Chalabreysse, et al.
JNCI Cancer Spectrum|April 25, 2020
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid TumorsSarina A Piha-Paul, Christine L Hann, Christopher A French, et al.
Journal for Immunotherapy of Cancer|February 5, 2026
Shared PRAME epitopes are T-cell targets in NUT carcinomaJeffrey L Jensen, Sara K Peterson, Maria J Sambade, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2021
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATEAndrew Dj Pearson, Steven G DuBois, Vickie Buenger, et al.
Pageof 9